• Home
• Company
  • About the Company
  • Management Team
  • Board of Directors
  • Company History
  • Careers
  • Philanthropy
  • Contact Us
• Research and Development
  • Development Pipeline
  • Diseases and Products
• Clinical Trials
  • Education
  • Information Request
• Business Development
  • Business Development Strategy
  • Partners and Collaborators
  • Information Request
• Investor Relations
  • Investor Home
  • Press Releases
  • Media Archive
  • Annual Reports
  • SEC Filings
  • Stock Quote - OSE
  • Stock Quote - Nasdaq
  • Historical Price Lookup
  • Investment Calculator
  • Analyst Coverage
  • Corporate Governance
  • Information Request

Diseases and Products

Click on the links below for more information about these products and their disease indications.

Core Candidates:

• MN-221 (Exacerbations of Asthma/COPD)
• MN-166 (Multiple Sclerosis)

Non-Core Candidates:

• MN-001 (Bronchial Asthma)
• MN-305 (Anxiety Disorders)
• MN-001 (Interstitial Cystitis)
• MN-221 (Preterm Labor)
• MN-029 (Cancer)
• MN-246 (Urinary Incontinence)

Copyright © 2007, MediciNova, Inc. All rights reserved. | Terms of Use | Contact Us
Site design by MJD Interactive Agency.